A Validated UHPLC–MS/MS Method to Quantify Eight Antibiotics in Quantitative Dried Blood Spots in Support of Pharmacokinetic Studies in Neonates
暂无分享,去创建一个
Qian Liu | Feifan Xie | Yu Yuan | Lanyu Liu
[1] S. Bode-Böger,et al. Quantification of ceftazidime/avibactam in human plasma and dried blood spots: Implications on stability and sample transport. , 2022, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] Sanwang Li,et al. An UPLC-PDA assay for simultaneous determination of seven antibiotics in human plasma. , 2021, Journal of pharmaceutical and biomedical analysis.
[3] R. Linden,et al. Development and validation of an assay for the measurement of gentamicin concentrations in dried blood spots using UHPLC-MS/MS. , 2021, Journal of pharmaceutical and biomedical analysis.
[4] S. Mallayasamy,et al. Validation of an HPLC method for estimation of cefotaxime from dried blood spot: alternative to plasma-based PK evaluation in neonates. , 2021, Bioanalysis.
[5] C. R. Stensvold,et al. Impact of Metronidazole Treatment and Dientamoeba Fragilis Colonization on Gut Microbiota Diversity , 2021, Journal of pediatric gastroenterology and nutrition.
[6] K. Sridharan,et al. Off-label drug use and the risk of medication errors in critically ill neonates: A conceptual pilot study. , 2021, The International journal of risk & safety in medicine.
[7] M. Sharland,et al. Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies , 2021, Clinical pharmacology and therapeutics.
[8] Christophe Stove,et al. Alternative Sampling Devices to Collect Dried Blood Microsamples: State-of-the-Art , 2021, Therapeutic drug monitoring.
[9] S. Robinson,et al. Little to Give, Much to Gain—What Can You Do With a Dried Blood Spot? , 2020, Current Environmental Health Reports.
[10] Jinson J. Erinjeri,et al. Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections , 2020, The Pediatric infectious disease journal.
[11] U. Tröger,et al. Stability of meropenem in plasma versus dried blood spots (DBS) , 2019, Journal of pharmaceutical and biomedical analysis.
[12] C. Stove,et al. Is the hematocrit still an issue in quantitative dried blood spot analysis? , 2019, Journal of pharmaceutical and biomedical analysis.
[13] G. Kearns,et al. Developmental Changes in Pharmacokinetics and Pharmacodynamics , 2018, Journal of clinical pharmacology.
[14] M. Breadmore,et al. Precise, accurate and user-independent blood collection system for dried blood spot sample preparation , 2018, Analytical and Bioanalytical Chemistry.
[15] N. Spooner,et al. Investigation of the effect of blood hematocrit and lipid content on the blood volume deposited by a disposable dried blood spot collection device , 2018, Journal of pharmaceutical and biomedical analysis.
[16] B. Poindexter,et al. Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates , 2017, Therapeutic drug monitoring.
[17] G. Tripodi,et al. Volumetric adsorptive microsampling‐liquid chromatography tandem mass spectrometry assay for the simultaneous quantification of four antibiotics in human blood: Method development, validation and comparison with dried blood spot , 2017, Journal of pharmaceutical and biomedical analysis.
[18] Kathrin Foerster,et al. Clinical feasibility of dried blood spots: Analytics, validation, and applications. , 2016, Journal of pharmaceutical and biomedical analysis.
[19] D. Tonoli,et al. The use of mass spectrometry to analyze dried blood spots. , 2016, Mass spectrometry reviews.
[20] B. Poindexter,et al. Developmental Pharmacokinetics of Piperacillin and Tazobactam Using Plasma and Dried Blood Spots from Infants , 2014, Antimicrobial Agents and Chemotherapy.
[21] P. Timmerman,et al. Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium. , 2013, Bioanalysis.
[22] K. Boussery,et al. Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry. , 2013, Talanta.
[23] G. la Marca,et al. Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots. , 2012, Journal of pharmaceutical and biomedical analysis.
[24] P. Timmerman,et al. EBF recommendation on the validation of bioanalytical methods for dried blood spots. , 2011, Bioanalysis.
[25] J. McElnay,et al. Dried blood spot assay for estimation of metronidazole concentrations in rats and its application in single animal drug pharmacokinetic study. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[26] J. Alffenaar,et al. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[27] M. Danhof,et al. The role of population PK–PD modelling in paediatric clinical research , 2010, European Journal of Clinical Pharmacology.
[28] J. McElnay,et al. Development and validation of a dried blood spot–HPLC assay for the determination of metronidazole in neonatal whole blood samples , 2010, Analytical and bioanalytical chemistry.
[29] A. Marsot. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children? , 2020, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[30] G. Carlucci,et al. Development of a dried blood spot HPLC-PDA method for the analysis of linezolid and ciprofloxacin in hospital-acquired pneumonia patients. , 2017, Drug testing and analysis.
[31] E. Woolf,et al. A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. , 2015, Bioanalysis.